Cargando…

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Detalles Bibliográficos
Autores principales: Quartuccio, Luca, Semerano, Luca, Benucci, Maurizio, Boissier, Marie-Christophe, De Vita, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de rhumatologie. Published by Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167227/
https://www.ncbi.nlm.nih.gov/pubmed/32321634
http://dx.doi.org/10.1016/j.jbspin.2020.03.011
_version_ 1783523540206616576
author Quartuccio, Luca
Semerano, Luca
Benucci, Maurizio
Boissier, Marie-Christophe
De Vita, Salvatore
author_facet Quartuccio, Luca
Semerano, Luca
Benucci, Maurizio
Boissier, Marie-Christophe
De Vita, Salvatore
author_sort Quartuccio, Luca
collection PubMed
description
format Online
Article
Text
id pubmed-7167227
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Société française de rhumatologie. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71672272020-04-20 Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome Quartuccio, Luca Semerano, Luca Benucci, Maurizio Boissier, Marie-Christophe De Vita, Salvatore Joint Bone Spine Editorial Société française de rhumatologie. Published by Elsevier Masson SAS. 2020-05 2020-04-19 /pmc/articles/PMC7167227/ /pubmed/32321634 http://dx.doi.org/10.1016/j.jbspin.2020.03.011 Text en © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Quartuccio, Luca
Semerano, Luca
Benucci, Maurizio
Boissier, Marie-Christophe
De Vita, Salvatore
Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
title Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
title_full Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
title_fullStr Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
title_full_unstemmed Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
title_short Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
title_sort urgent avenues in the treatment of covid-19: targeting downstream inflammation to prevent catastrophic syndrome
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167227/
https://www.ncbi.nlm.nih.gov/pubmed/32321634
http://dx.doi.org/10.1016/j.jbspin.2020.03.011
work_keys_str_mv AT quartuccioluca urgentavenuesinthetreatmentofcovid19targetingdownstreaminflammationtopreventcatastrophicsyndrome
AT semeranoluca urgentavenuesinthetreatmentofcovid19targetingdownstreaminflammationtopreventcatastrophicsyndrome
AT benuccimaurizio urgentavenuesinthetreatmentofcovid19targetingdownstreaminflammationtopreventcatastrophicsyndrome
AT boissiermariechristophe urgentavenuesinthetreatmentofcovid19targetingdownstreaminflammationtopreventcatastrophicsyndrome
AT devitasalvatore urgentavenuesinthetreatmentofcovid19targetingdownstreaminflammationtopreventcatastrophicsyndrome